Correction to: “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”

OBJECTIVE: Recent studies have raised concerns about the cardiovascular safety of dipeptidyl peptidase-4 (DPP4) inhibitors. We performed a systematic review and meta-analysis to compare the cardiovascular outcomes of sulfonylureas (SUs) versus DPP4 inhibitors in combination with metformin. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Won Kyeong, Kang, Jeehoon, Kim, Hyo-Soo, Park, Kyung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Lipidology and Atherosclerosis 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792822/
https://www.ncbi.nlm.nih.gov/pubmed/35118026
http://dx.doi.org/10.12997/jla.2022.11.1.89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792822/
https://www.ncbi.nlm.nih.gov/pubmed/35118026
http://dx.doi.org/10.12997/jla.2022.11.1.89

Ejemplares similares